12/30/2020 7:08:40 AM
Dye & Durham Acquires Majority Stake In Courthouse Solutions
11/10/2020 7:09:01 AM
Dye & Durham Q1 Net Loss $15.0 Mln Vs Net Loss $4.7 Mln Last Year
10/29/2014 7:18:32 AM
Cipher Pharma Q3 EPS C$0.33 Vs C$0.13 Prior Year
10/1/2014 8:34:08 AM
Ranbaxy Launches ABSORICA 25 Mg And 35 Mg Capsules In US Market
7/30/2014 7:17:45 AM
Cipher Pharmaceuticals Q2 EPS C$0.17 Vs C$0.12 Last Year
7/24/2014 8:15:53 AM
Cipher Pharma, Ranbaxy Announce Distribution Agreement For Isotretinoin Product In Brazil
5/2/2014 7:10:28 AM
Cipher Pharma Q1 Net Income $3.6 Mln Or $0.15/basic Shr Vs. $1.5 Mln Or $0.06/basic Shr Last Year
3/14/2014 7:06:34 AM
Cipher Pharmaceuticals Says Larry Andrews Will Be Stepping Down As President And CEO
2/26/2014 7:11:41 AM
Cipher Pharma Q4 Net Income $25 Mln Vs $2.5 Mln Prior Year
2/5/2014 7:37:42 AM
Cipher Pharma Appoints Gerald McDole As Chair
10/30/2013 11:39:29 AM
Cipher Pharmaceuticals Posts Q3 EPS Of $0.13 Vs. $0.03 Year Ago
10/30/2013 7:15:35 AM
Cipher Q3 EPS C$0.13 Vs. C$0.03 Last Year
7/31/2013 7:23:32 AM
Cipher Pharma Q2 EPS C$0.12 Vs C$0.01 Prior Year
7/2/2013 8:34:52 AM
Cipher Introduces Epuris™ Capsules In Canadian Market